Top compounds associated with response to LRRC9


Feature Type Standardized
Nominal ANOVA
mRNA paclitaxel CTRPv2 pan-cancer AAC 0.043 0.2
mRNA clofarabine CTRPv2 pan-cancer AAC 0.038 0.2
mRNA lapatinib gCSI pan-cancer AAC -0.071 0.2
mRNA NVP-231 CTRPv2 pan-cancer AAC 0.042 0.2
mRNA rigosertib CTRPv2 pan-cancer AAC 0.042 0.2
mRNA Gefitinib CTRPv2 pan-cancer AAC -0.047 0.2
mRNA FQI-2 CTRPv2 pan-cancer AAC 0.041 0.2
mRNA BRD-K35604418 CTRPv2 pan-cancer AAC 0.047 0.2
mRNA BRD9876 CTRPv2 pan-cancer AAC 0.048 0.2
mRNA Curcumin CTRPv2 pan-cancer AAC 0.043 0.2
Download CSV